Robert Stein, MBBS, PhD, discusses data from the OPTIMA trial in ER+, HER2– early breast cancer.
Robert Stein, MBBS, PhD
Advertisement
Robert Stein, MBBS, PhD, is an honorary consultant oncologist at University College London (UCL) Hospitals and a professor of breast oncology at UCL Cancer Institute.
Articles by Robert Stein, MBBS, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts Third RP1 BLA Resubmission With Nivolumab in Advanced Melanoma
2
MAIC Shows OS Benefit With Mogamulizumab vs Vorinostat in Cutaneous T-Cell Lymphoma Subtypes
3
From "Not Curable" to "May Be Curable": Joshua Richter, MD, on the New Reality of Multiple Myeloma
4
Analysis Identifies Potential Response, Resistance Biomarkers to Mogamulizumab in R/R Mycosis Fungoides/Sézary Syndrome
5